BRIEF-Merck To Acquire Verona Pharma for $10 billion-February 2024-www.financetom.com

BRIEF-Merck To Acquire Verona Pharma for $10 billion

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Merck To Acquire Verona Pharma for $10 billion

Jul 9, 2025 4:00 AM

July 9 (Reuters) - Verona Pharma PLC:

* MERCK TO ACQUIRE VERONA PHARMA, EXPANDING ITS PORTFOLIO TO

INCLUDE OHTUVAYRE® (ENSIFENTRINE), A FIRST-IN-CLASS COPD

MAINTENANCE TREATMENT FOR ADULTS AND EXPECTED TO DRIVE GROWTH

INTO THE NEXT DECADE

* VERONA PHARMA PLC - MERCK TO BUY VERONA PHARMA FOR $10

BILLION

* VERONA PHARMA PLC - MERCK TO PAY $107 PER ADS IN VERONA

PHARMA

DEAL

* VERONA PHARMA PLC - DEAL EXPECTED TO CLOSE IN Q4 2025

* VERONA PHARMA PLC - MERCK AND VERONA PHARMA BOARDS APPROVE

DEAL

Source text:

Further company coverage:

Previous page： Bausch Health Swings to Q4 Profit, Revenue Increases -- Shares Rise After Hours Next page： Expedia Group Insider Sold Shares Worth $1,028,500, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Bausch Health Swings to Q4 Profit, Revenue Increases -- Shares Rise After Hours

Feb 19, 2025

05:12 PM EST, 02/19/2025 (MT Newswires) -- Bausch Health ( BHC ) reported Q4 earnings Wednesday of $0.25 per diluted share, compared with a per-share loss of $0.11 a year earlier. Two analysts polled by FactSet expected $0.23. Revenue for the quarter ended Dec. 31 was $2.56 billion, up from $2.41 billion a year earlier. Analysts surveyed by FactSet expected...

Expedia Group Insider Sold Shares Worth $1,028,500, According to a Recent SEC Filing

Feb 19, 2025

05:12 PM EST, 02/19/2025 (MT Newswires) -- Robert J Dzielak, Chief Legal Officer & Secretary, on February 15, 2025, sold 5,000 shares in Expedia Group ( EXPE ) for $1,028,500. Following the Form 4 filing with the SEC, Dzielak has control over a total of 74,502 commo shares of the company, with 74,502 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1324424/000122520825001978/xslF345X05/doc4.xml ...

Manulife's profit climbs on wealth management strength, Asia growth

Feb 19, 2025

Feb 19 (Reuters) - Manulife Financial ( MFC ) posted a 6% jump in fourth-quarter profit on Wednesday, bolstered by a thriving wealth and asset management business and strong growth in Asia. The company's core earnings jumped to C$1.91 billion ($1.34 billion), or C$1.03 per share, in the three months ended December 31, from C$1.77 billion, or 92 Canadian cents...

Samsara Insider Sold Shares Worth $767,000, According to a Recent SEC Filing

Feb 19, 2025

05:13 PM EST, 02/19/2025 (MT Newswires) -- Adam Eltoukhy, Executive Vice President, Chief Legal Officer and Secretary, on February 14, 2025, sold 13,000 shares in Samsara (IOT) for $767,000. Following the Form 4 filing with the SEC, Eltoukhy has control over a total of 436,905 Class A common shares of the company, with 331,106 shares held directly and 105,799 controlled...